Gerjon J Ikink
3PUBLICATIONS
1CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Jan 13, 2018
Insertional mutagenesis in a HER2-positive breast cancer model reveals ERAS as a driver of cancer and therapy resistance.Gerjon J Ikink, Mandy Boer, Elvira R M Bakker
|Apr 13, 2017
Insulin receptor substrate 4 (IRS4) is a constitutive active oncogenic driver collaborating with HER2 and causing therapeutic resistance.Gerjon J Ikink, John Hilkens
|Nov 24, 2016
IRS4 induces mammary tumorigenesis and confers resistance to HER2-targeted therapy through constitutive PI3K/AKT-pathway hyperactivation.Gerjon J Ikink, Mandy Boer, Elvira R M Bakker
Pageof 1
